SERES THERAPEUTICS |
USA |
Gesundheit |
US81750R2013 / A413XF |
1S90 (Frankfurt) / MCRB (NASDAQ) |
FRA:1S90, ETR:1S90, 1S90:GR, NASDAQ:MCRB |
- |
https://www.serestherapeu.. |
Seres Therapeutics, Inc., a clinical-stage company..
>Volltext.. |
132.64 Mio. EUR |
168.3 Mio. EUR |
- |
-88.64 Mio. EUR |
-52.02 Mio. EUR |
-6.78 EUR |
74.89 Mio. EUR |
38.87 Mio. EUR |
-51.34 Mio. EUR |
1.47 |
-100% |
65.93% |
- |
- |
- |
- |
SERES THERAPEUTICS, SERES THERAPEUTIC |
19.08.25 |
|